On October 5, 2023, Treatment.Com International Inc. closed the transaction. The company amended the terms of the transaction and issued 2,475,000 common shares in the capital of the company at a price of CAD 0.15 per common share, for aggregate gross proceeds of up to CAD 371,250. The company has received CAD 350,234 pursuant to Regulation D and included participation from 2 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.69 CAD | -1.43% | -2.82% | +62.35% |
Apr. 17 | Treatment.com AI Inc. Announces New Additions to Its Medical Education Suite | CI |
Apr. 10 | Treatment.com AI Partnering With aiXplain Inc. to Extend Access to its Global Library of Medicine | MT |
1st Jan change | Capi. | |
---|---|---|
+62.35% | 19.77M | |
+4.36% | 32.47B | |
+14.14% | 7.45B | |
+22.93% | 3.89B | |
-16.29% | 3.17B | |
-25.96% | 1.28B | |
-36.14% | 1.09B | |
-35.42% | 902M | |
-0.13% | 893M | |
-24.12% | 857M |
- Stock Market
- Equities
- TRUE Stock
- News Treatment.com AI Inc.
- Treatment.Com International Inc. announced that it has received CAD 0.37125 million in funding